tradingkey.logo

Evolent Health Inc

EVH
4.310USD
+0.040+0.94%
Close 11/25, 16:00ETQuotes delayed by 15 min
480.96MMarket Cap
LossP/E TTM

Evolent Health Inc

4.310
+0.040+0.94%

More Details of Evolent Health Inc Company

Evolent Health, Inc. is a health care company connecting care for people with complex conditions like cancer, cardiovascular disease, and musculoskeletal diagnoses. The Company offers three primary solutions: specialty care management services, total cost of care management and administrative services. It provides comprehensive quality management for oncology and cardiology patients from diagnosis through advance care planning services as well as identifying quality, lowest cost of care for outpatient orthopedic surgeries. Its total cost of care management solution enables providers to manage populations they may be accountable for under value-based contracts with payers or accountable care organizations (ACO) contracts with Centers for Medicare and Medicaid Services (CMS). Its administrative services solution includes integrated value-based care platform designed to help customers manage and administer patient health in a cost-effective manner.

Evolent Health Inc Info

Ticker SymbolEVH
Company nameEvolent Health Inc
IPO dateJun 05, 2015
CEOMr. Seth Blackley
Number of employees4500
Security typeOrdinary Share
Fiscal year-endJun 05
Address1812 North Moore St, Suite 1705
CityARLINGTON
Stock exchangeNYSE Consolidated
CountryUnited States of America
Postal code22209
Phone15713896000
Websitehttps://www.evolent.com/
Ticker SymbolEVH
IPO dateJun 05, 2015
CEOMr. Seth Blackley

Company Executives of Evolent Health Inc

Name
Name/Position
Position
Shareholding
Change
Mr. Seth Blackley
Mr. Seth Blackley
Chief Executive Officer, Co-Founder, Director
Chief Executive Officer, Co-Founder, Director
508.13K
+15.23%
Mr. John Paul Johnson
Mr. John Paul Johnson
Chief Strategy Officer
Chief Strategy Officer
184.49K
+16.01%
Mr. Peter J. Grua
Mr. Peter J. Grua
Independent Director
Independent Director
82.65K
+36.23%
Ms. Cheryl M. Scott
Ms. Cheryl M. Scott
Independent Director
Independent Director
73.48K
+42.68%
Mr. Richard M. Jelinek
Mr. Richard M. Jelinek
Independent Chairman of the Board
Independent Chairman of the Board
66.44K
+49.44%
Ms. Kim Keck
Ms. Kim Keck
Independent Director
Independent Director
61.50K
+55.61%
Mr. Aammaad Shams
Mr. Aammaad Shams
Chief Accounting Officer
Chief Accounting Officer
55.40K
-4.43%
Mr. Craig A. Barbarosh
Mr. Craig A. Barbarosh
Independent Director
Independent Director
53.94K
+68.78%
Dr. Toyin Ajayi, M.D.
Dr. Toyin Ajayi, M.D.
Independent Director
Independent Director
34.07K
+181.72%
Mr. Shawn M. Guertin
Mr. Shawn M. Guertin
Director
Director
21.98K
--
View more
Name
Name/Position
Position
Shareholding
Change
Mr. Seth Blackley
Mr. Seth Blackley
Chief Executive Officer, Co-Founder, Director
Chief Executive Officer, Co-Founder, Director
508.13K
+15.23%
Mr. John Paul Johnson
Mr. John Paul Johnson
Chief Strategy Officer
Chief Strategy Officer
184.49K
+16.01%
Mr. Peter J. Grua
Mr. Peter J. Grua
Independent Director
Independent Director
82.65K
+36.23%
Ms. Cheryl M. Scott
Ms. Cheryl M. Scott
Independent Director
Independent Director
73.48K
+42.68%
Mr. Richard M. Jelinek
Mr. Richard M. Jelinek
Independent Chairman of the Board
Independent Chairman of the Board
66.44K
+49.44%
Ms. Kim Keck
Ms. Kim Keck
Independent Director
Independent Director
61.50K
+55.61%

Revenue Breakdown

Currency: USDUpdated: Mon, Feb 24
Currency: USDUpdated: Mon, Feb 24
FY2021
FY2020
FY2019
By BusinessUSD
Name
Revenue
Proportion
Platform and operations
896.75M
98.77%
Transformation services
11.20M
1.23%
Relevant data have not been disclosed by the company yet.
By Business
By Region
By BusinessUSD
Name
Revenue
Proportion
Platform and operations
896.75M
98.77%
Transformation services
11.20M
1.23%

Shareholding Stats

Updated: Tue, Nov 18
Updated: Tue, Nov 18
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
Cadian Capital Management LP
10.51%
The Vanguard Group, Inc.
9.81%
BlackRock Institutional Trust Company, N.A.
7.04%
Fidelity Management & Research Company LLC
6.88%
Morgan Stanley & Co. LLC
6.71%
Other
59.05%
Shareholders
Shareholders
Proportion
Cadian Capital Management LP
10.51%
The Vanguard Group, Inc.
9.81%
BlackRock Institutional Trust Company, N.A.
7.04%
Fidelity Management & Research Company LLC
6.88%
Morgan Stanley & Co. LLC
6.71%
Other
59.05%
Shareholder Types
Shareholders
Proportion
Investment Advisor
51.75%
Hedge Fund
33.00%
Investment Advisor/Hedge Fund
25.97%
Research Firm
11.11%
Individual Investor
1.68%
Venture Capital
0.61%
Pension Fund
0.60%
Bank and Trust
0.43%
Sovereign Wealth Fund
0.16%

Institutional Shareholding

Updated: Wed, Oct 1
Updated: Wed, Oct 1
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2025Q3
583
129.03M
115.62%
-25.34M
2025Q2
591
129.14M
110.03%
-13.77M
2025Q1
622
133.55M
113.84%
-13.20M
2024Q4
617
129.23M
110.86%
-26.99M
2024Q3
604
139.74M
121.52%
-23.43M
2024Q2
570
138.51M
120.74%
-16.12M
2024Q1
562
134.93M
117.72%
-21.70M
2023Q4
551
135.59M
118.01%
-17.32M
2023Q3
543
130.97M
115.67%
-18.07M
2023Q2
540
125.90M
111.75%
-15.65M
View more

Shareholder Activity

Name
Shares Held
Proportion
Change
Chg %
Date
Cadian Capital Management LP
10.42M
8.87%
-369.90K
-3.43%
Jun 30, 2025
The Vanguard Group, Inc.
10.90M
9.28%
-16.63K
-0.15%
Jun 30, 2025
BlackRock Institutional Trust Company, N.A.
7.75M
6.59%
-36.76K
-0.47%
Jun 30, 2025
Fidelity Management & Research Company LLC
6.37M
5.42%
+3.17M
+98.79%
Jun 30, 2025
Morgan Stanley & Co. LLC
7.35M
6.26%
+4.38M
+147.31%
Jun 30, 2025
Eventide Asset Management, LLC
4.09M
3.48%
-1.99M
-32.75%
Jun 30, 2025
Engaged Capital, LLC
5.85M
4.98%
+675.00K
+13.03%
Jun 30, 2025
William Blair Investment Management, LLC
4.32M
3.68%
-79.05K
-1.80%
Jun 30, 2025
UBS Financial Services, Inc.
2.81M
2.39%
+269.54K
+10.60%
Jun 30, 2025
View more

Related ETFs

Updated: Thu, Nov 6
Updated: Thu, Nov 6
Name
Proportion
Fidelity Digital Health ETF
1.14%
Global X HealthTech ETF
0.93%
JPMorgan Fundamental Data Science Small Core ETF
0.2%
Optimize Strategy Index ETF
0.19%
iShares U.S. Healthcare Providers ETF
0.16%
Avantis US Small Cap Equity ETF
0.09%
Invesco RAFI US 1500 Small-Mid ETF
0.08%
SPDR S&P Kensho New Economies Composite ETF
0.08%
iShares Russell 2000 Value ETF
0.05%
JPMorgan BetaBuilders US Small Cap Equity ETF
0.05%
View more
Fidelity Digital Health ETF
Proportion1.14%
Global X HealthTech ETF
Proportion0.93%
JPMorgan Fundamental Data Science Small Core ETF
Proportion0.2%
Optimize Strategy Index ETF
Proportion0.19%
iShares U.S. Healthcare Providers ETF
Proportion0.16%
Avantis US Small Cap Equity ETF
Proportion0.09%
Invesco RAFI US 1500 Small-Mid ETF
Proportion0.08%
SPDR S&P Kensho New Economies Composite ETF
Proportion0.08%
iShares Russell 2000 Value ETF
Proportion0.05%
JPMorgan BetaBuilders US Small Cap Equity ETF
Proportion0.05%

Dividend

A total of 0.00 USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data

Stock Split

Date
Type
Ratio
No Data
Date
Type
Ratio
No Data

FAQs

Who are the top five shareholders of Evolent Health Inc?

The top five shareholders of Evolent Health Inc are:
Cadian Capital Management LP holds 10.42M shares, accounting for 8.87% of the total shares.
The Vanguard Group, Inc. holds 10.90M shares, accounting for 9.28% of the total shares.
BlackRock Institutional Trust Company, N.A. holds 7.75M shares, accounting for 6.59% of the total shares.
Fidelity Management & Research Company LLC holds 6.37M shares, accounting for 5.42% of the total shares.
Morgan Stanley & Co. LLC holds 7.35M shares, accounting for 6.26% of the total shares.

What are the top three shareholder types of Evolent Health Inc?

The top three shareholder types of Evolent Health Inc are:
Cadian Capital Management LP
The Vanguard Group, Inc.
BlackRock Institutional Trust Company, N.A.

How many institutions hold shares of Evolent Health Inc (EVH)?

As of 2025Q3, 583 institutions hold shares of Evolent Health Inc, with a combined market value of approximately 129.03M, accounting for 115.62% of the total shares. Compared to 2025Q2, institutional shareholding has increased by 5.59%.

What is the biggest source of revenue for Evolent Health Inc?

In FY2021, the Platform and operations business generated the highest revenue for Evolent Health Inc, amounting to 896.75M and accounting for 98.77% of total revenue.
KeyAI